Metformin and Congenital Nephrogenic Diabetes Insipidus

Summary

The purpose of this study is to determine whether metformin can increase urine concentration (osmolality) and decrease the amount of urine in patients with congenital nephrogenic diabetes insipidus (NDI).

Timeline

Start

2015-09

Primary completion

2017-06

Completion

2017-06

Outcome

Outcome not reported

Stopped: “Lack of effect in initial subjects”

Drugs

Indications